The head of the U.S. Food and Drug Administration on Friday approved a long-term drug to treat people who have bad straight hair.
The drug, known as Cynosure, is designed to treat patients who have the disease called cystic fibrosis, also known as CF.
The FDA said the drug has been shown to reduce the amount of fluid in the scalp and help keep it clean, but there’s still a long way to go before it becomes widely available.
More:The drug can be used as a first-line treatment, but if patients have other health problems, it can be extended to two months, or up to 12 months.
It’s not approved for treatment of CF.
It was originally approved for CF in 2013, but it was not approved by the FDA until last year.
The Food and Drugs Administration approved Cynocolor for adults and children between 18 and 49 years old in February.
The agency said the approval of Cynoloc can help patients with other conditions and is intended to provide patients with a more timely and less expensive treatment option.
There are currently more than 7 million people in the U, including many people with CF.CF is an autoimmune disease in which a person’s immune system mistakenly attacks a protein called an adhesion molecule.
This results in the body breaking down the hair follicles in the hair shaft and hair follicle cells, causing them to develop abnormally.
The condition can be life-threatening and can lead to loss of hair.
Symptoms of cystic hair include pain, redness, dryness, and a lump on the scalp.